NCT00405769
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Chestnut Hill Hospital Philadelphia, Pennsylvania, United States
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,337 public trials
328 recruiting studies
Lipid Metabolism Disorders trial results
Completed
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
NCT00139061
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Bordeaux Cauderan, France
- Pfizer Investigational Site Briollay, France
NCT00134485
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Washington D.C., District of Columbia, United States
- Pfizer Investigational Site Lutz, Florida, United States
- Pfizer Investigational Site Tampa, Florida, United States
NCT00546182
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, Hypercholesterolemia, +6 more
- Locations
-
- Gil Medical Center, Gachon University Incheon, South Korea
Completed
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
NCT00195793
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Completed
Antioxidant Functions of Lipoic Acid
NCT00065624
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00404001
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Microbia Investigational Site Birmingham, Alabama, United States
- Microbia Investigational Site Los Angeles, California, United States
- Microbia Investigational Site Walnut Creek, California, United States
- Microbia Investigational Site New Port Richey, Florida, United States
Completed
Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults
NCT00422266
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- National Thermal Power Corporation Delhi, Badarpur, India
NCT00069524
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +17 more
- Locations
-
- General Clinical Research Center, San Francisco General Hospital San Francisco, California, United States
Completed
Effects of Various Higher Fat and Lower Fat Snacks on Cardiovascular Risk Factors in Men and Women.
NCT00349765
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
Not specified